CO5210947A1 - Composiciones inmunogenicas que incluyen un antigeno polisacarido de streptoccus pneumoniae - Google Patents

Composiciones inmunogenicas que incluyen un antigeno polisacarido de streptoccus pneumoniae

Info

Publication number
CO5210947A1
CO5210947A1 CO00027743A CO00027743A CO5210947A1 CO 5210947 A1 CO5210947 A1 CO 5210947A1 CO 00027743 A CO00027743 A CO 00027743A CO 00027743 A CO00027743 A CO 00027743A CO 5210947 A1 CO5210947 A1 CO 5210947A1
Authority
CO
Colombia
Prior art keywords
polysaccharide
polysaccharides
antigen
conjugated
protein
Prior art date
Application number
CO00027743A
Other languages
English (en)
Inventor
Carine Capiau
Marguerite Deschamps
Michel Desmons Pierre
Laferriere Craig Antony Joseph
Jan Poolman
Jean Paul Prieels
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909077.1A external-priority patent/GB9909077D0/en
Priority claimed from GBGB9909466.6A external-priority patent/GB9909466D0/en
Priority claimed from GBGB9916677.9A external-priority patent/GB9916677D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CO5210947A1 publication Critical patent/CO5210947A1/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un antígeno conjugado polisacárido que comprende un antígeno polisacárido derivado de una bacteria patógena conjugada con proteína D de Haemophilus influenzae o un fragmento de proteína D de ésta.Un polisacárido conjugado como se reivindica en la reivindicación 1, en el que el antígeno polisacárido se selecciona del grupo consistente en: polisacáridos Vi de Salmonella typhi, polisacáridos meningocóccicos, polisacáridos y polisacáridos modificados de meningococos del grupo B, polisacáridos de Staphylococcus aureus, polisacáridos de Streptococcus agalactae, polisacáridos de Streptococcus pneumoniae, polisacáridos de micobacterias, polisacáridos de Cryptococcus neoformans, lipopolisacáridos de Haemophilus influenzae no tipificables, polisacárido capsular de Haemophilus influenzae b, lipopolisacáridos de Moraxella catarrhalis, lipopolisacáridos de Shigella sonnei y lipopéptidofosfoglicanos (LPPG) de Trypanosoma cruzi.1Una composición inmunogénica que comprende polisacáridos capsulares conjugados de streptococcus pneumoiae, haemophilus influenzae b, meningococos C y meningococos Y, en la que la proteína vehículo para al menos uno de los polisacáridos es la proteína D de H. Influenzae.
CO00027743A 1999-04-20 2000-04-14 Composiciones inmunogenicas que incluyen un antigeno polisacarido de streptoccus pneumoniae CO5210947A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909077.1A GB9909077D0 (en) 1999-04-20 1999-04-20 Novel compositions
GBGB9909466.6A GB9909466D0 (en) 1999-04-23 1999-04-23 Vaccines
GBGB9916677.9A GB9916677D0 (en) 1999-07-15 1999-07-15 Vaccine

Publications (1)

Publication Number Publication Date
CO5210947A1 true CO5210947A1 (es) 2002-10-30

Family

ID=40956460

Family Applications (3)

Application Number Title Priority Date Filing Date
CO00027740A CO5241278A1 (es) 1999-04-20 2000-04-14 Vacuna
CO00027743A CO5210947A1 (es) 1999-04-20 2000-04-14 Composiciones inmunogenicas que incluyen un antigeno polisacarido de streptoccus pneumoniae
CO00027739A CO5241277A1 (es) 1999-04-20 2000-04-14 Vacuna

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CO00027740A CO5241278A1 (es) 1999-04-20 2000-04-14 Vacuna

Family Applications After (1)

Application Number Title Priority Date Filing Date
CO00027739A CO5241277A1 (es) 1999-04-20 2000-04-14 Vacuna

Country Status (1)

Country Link
CO (3) CO5241278A1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9714283B2 (en) 2014-10-28 2017-07-25 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US9969793B2 (en) 2014-10-28 2018-05-15 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10683343B2 (en) 2014-10-28 2020-06-16 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US11339206B2 (en) 2014-10-28 2022-05-24 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US11780906B2 (en) 2014-10-28 2023-10-10 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11084870B2 (en) 2017-03-15 2021-08-10 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11897943B2 (en) 2017-03-15 2024-02-13 Adma Biomanufacturing, Llc Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Also Published As

Publication number Publication date
CO5241278A1 (es) 2003-01-31
CO5241277A1 (es) 2003-01-31

Similar Documents

Publication Publication Date Title
Chatterjee et al. Lipopolysaccharides of Vibrio cholerae: I. Physical and chemical characterization
BRPI0408094A (pt) processo para purificação de uma citolisina bacteriana, citolisina bacteriana, conjugado de polissacarìdeo capsular-pneumolisina bacteriano, composição imunogênica, vacina, processo de produção da vacina, método de tratamento ou prevenção de infecção por streptococcus pneumoniae, e, uso da pneumolisina ou do conjugado de polissacarìdeo-pneumolisina bacteriano
CN1318446C (zh) 莫拉氏菌属(moraxella)运铁蛋白之受体蛋白
BR9808772A (pt) Composição de vacina multivalente com carreadora misturada
KR920003982A (ko) 면역원성 콘쥬게이트 및 이를 함유하는 백신 조성물
HUP0002475A2 (hu) Módosított immunogén pneumolizinkészítmények mint vakcinák
SI20008B (en) Improved meningococcal polysaccharide conjugate vaccine
DE69315993T2 (de) Konjugate aus hitzeshockproteinen und oligo- oder polysacchariden
CA2366314A1 (en) Protein d from haemophilus influenzae as a carrier protein in combination vaccines
DE69118389T2 (de) Verbesserte vakzinzusammensetzung
PT1235589E (pt) Composições compreendendo antigénios da neisseria meningitidis dos serogrupos b e c, e outro antigénio
MXPA05009351A (es) Conjugados de polisacarido-proteina portadora adhesina superficial de estafilococo para inmunizacion contra infecciones nosocomiales.
CY1114041T1 (el) Ενεσιμα εμβολια εναντι πολλαπλων οροομαδων μηνιγγιτιδοκοκκου
TW200514569A (en) Vaccine composition
NO975366L (no) Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav
AU587865B2 (en) Conjucated vaccines against infections by gram-negative bacteria, process for their preparation and use thereof
CO5210947A1 (es) Composiciones inmunogenicas que incluyen un antigeno polisacarido de streptoccus pneumoniae
US6344200B1 (en) Lactoferrin receptor protein
DE69126183D1 (de) LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente
KR910015306A (ko) 피부염 치료용 약제
EP1035860A4 (en) NON-TOXIC IMMUNE-STIMULATING ENTEROTOXIN COMPOSITIONS
Figueirêdo et al. Thiol-independent activity of a cholesterol-binding enterohemolysin produced by enteropathogenic Escherichia coli
Bartram Some rare mosses from northeastern Pennsylvania
JPS55160719A (en) Remedy for microbial infectious disease
Idris Characterization of Actinobacillus pleuropneumoniae hemolysin and its role in porcine Actinobacillus pleuropneumonia

Legal Events

Date Code Title Description
FC Application refused